COVID-19 Impact on Global Autologous Cell Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Autologous Cell Therapy Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Autologous Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Bone Marrow
  • 1.4.3 Epidermis
• 1.5 Market by Application
  • 1.5.1 Global Autologous Cell Therapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Neurology
  • 1.5.3 Orthopedics
  • 1.5.4 Cancer
  • 1.5.5 Wound Healing
  • 1.5.6 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Autologous Cell Therapy Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Autologous Cell Therapy Industry
    • 1.6.1.1 Autologous Cell Therapy Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Autologous Cell Therapy Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Autologous Cell Therapy Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Autologous Cell Therapy Market Perspective (2015-2026)
• 2.2 Autologous Cell Therapy Growth Trends by Regions
  • 2.2.1 Autologous Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Autologous Cell Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Autologous Cell Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Autologous Cell Therapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Autologous Cell Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Autologous Cell Therapy Players by Market Size
  • 3.1.1 Global Top Autologous Cell Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Autologous Cell Therapy Market Concentration Ratio
  • 3.2.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2019
• 3.3 Autologous Cell Therapy Key Players Head office and Area Served
• 3.4 Key Players Autologous Cell Therapy Product Solution and Service
• 3.5 Date of Enter into Autologous Cell Therapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Autologous Cell Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Autologous Cell Therapy Breakdown Data by Application (2015-2026)

• 5.1 Global Autologous Cell Therapy Market Size by Application (2015-2020)
• 5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Autologous Cell Therapy Market Size (2015-2020)
• 6.2 Autologous Cell Therapy Key Players in North America (2019-2020)
• 6.3 North America Autologous Cell Therapy Market Size by Type (2015-2020)
• 6.4 North America Autologous Cell Therapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Autologous Cell Therapy Market Size (2015-2020)
• 7.2 Autologous Cell Therapy Key Players in Europe (2019-2020)
• 7.3 Europe Autologous Cell Therapy Market Size by Type (2015-2020)
• 7.4 Europe Autologous Cell Therapy Market Size by Application (2015-2020)

8 China

• 8.1 China Autologous Cell Therapy Market Size (2015-2020)
• 8.2 Autologous Cell Therapy Key Players in China (2019-2020)
• 8.3 China Autologous Cell Therapy Market Size by Type (2015-2020)
• 8.4 China Autologous Cell Therapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Autologous Cell Therapy Market Size (2015-2020)
• 9.2 Autologous Cell Therapy Key Players in Japan (2019-2020)
• 9.3 Japan Autologous Cell Therapy Market Size by Type (2015-2020)
• 9.4 Japan Autologous Cell Therapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Autologous Cell Therapy Market Size (2015-2020)
• 10.2 Autologous Cell Therapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Autologous Cell Therapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Autologous Cell Therapy Market Size by Application (2015-2020)

11 India

• 11.1 India Autologous Cell Therapy Market Size (2015-2020)
• 11.2 Autologous Cell Therapy Key Players in India (2019-2020)
• 11.3 India Autologous Cell Therapy Market Size by Type (2015-2020)
• 11.4 India Autologous Cell Therapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Autologous Cell Therapy Market Size (2015-2020)
• 12.2 Autologous Cell Therapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Autologous Cell Therapy Market Size by Type (2015-2020)
• 12.4 Central & South America Autologous Cell Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 BioTime
  • 13.1.1 BioTime Company Details
  • 13.1.2 BioTime Business Overview and Its Total Revenue
  • 13.1.3 BioTime Autologous Cell Therapy Introduction
  • 13.1.4 BioTime Revenue in Autologous Cell Therapy Business (2015-2020))
  • 13.1.5 BioTime Recent Development
• 13.2 Pharmicell
  • 13.2.1 Pharmicell Company Details
  • 13.2.2 Pharmicell Business Overview and Its Total Revenue
  • 13.2.3 Pharmicell Autologous Cell Therapy Introduction
  • 13.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2015-2020)
  • 13.2.5 Pharmicell Recent Development
• 13.3 BrainStorm Cell Therapeutics
  • 13.3.1 BrainStorm Cell Therapeutics Company Details
  • 13.3.2 BrainStorm Cell Therapeutics Business Overview and Its Total Revenue
  • 13.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction
  • 13.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020)
  • 13.3.5 BrainStorm Cell Therapeutics Recent Development
• 13.4 Opexa Therapeutics
  • 13.4.1 Opexa Therapeutics Company Details
  • 13.4.2 Opexa Therapeutics Business Overview and Its Total Revenue
  • 13.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction
  • 13.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020)
  • 13.4.5 Opexa Therapeutics Recent Development
• 13.5 Vericel Corporation
  • 13.5.1 Vericel Corporation Company Details
  • 13.5.2 Vericel Corporation Business Overview and Its Total Revenue
  • 13.5.3 Vericel Corporation Autologous Cell Therapy Introduction
  • 13.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2015-2020)
  • 13.5.5 Vericel Corporation Recent Development
• 13.6 Regeneus
  • 13.6.1 Regeneus Company Details
  • 13.6.2 Regeneus Business Overview and Its Total Revenue
  • 13.6.3 Regeneus Autologous Cell Therapy Introduction
  • 13.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2015-2020)
  • 13.6.5 Regeneus Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer